To overcome this issue, we decided to assess the chemokine production (CCL2, CCL4, CCL5, CX3CL1 and CXCL10) in a human BBB model with PBMCs obtained from three groups of patients as follow: controls, mild AD and moderated AD patients. The gene discussed is CCL4; the disease is Alzheimer disease.